Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J01 ANTIBACTERIALS FOR SYSTEMIC USE
J01D OTHER BETA-LACTAM ANTIBACTERIALS
J01DH Carbapenems
J01DH52 Meropenem and vaborbactam
D11015 Meropenem and vaborbactam <US>
USP drug classification [BR:br08302]
Antibacterials
Carbapenems
Meropenem/ Vaborbactam
D11015 Meropenem and vaborbactam
Antimicrobials [BR:br08307]
Antibacterials
Cell wall biosynthesis inhibitor, beta-lactam
Carbapenem
D11015 Meropenem and vaborbactam <US>
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Cell wall biosynthesis inhibitor, beta-lactam
Carbapenem
D11015 Meropenem and vaborbactam
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11015
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11015
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11015
